The fabrication of integrated circuits includes many diverse processing steps. One of the operations frequently employed is the deposition of a dielectric film. The film may be deposited on a relatively flat substrate, or it may be deposited into a gap between features patterned over or into silicon substrates. One method of depositing such a film is through plasma enhanced atomic layer deposition (PEALD). In this type of method, several operations are undertaken in a cyclic manner to deposit a conformal film. Typically, PEALD processes include the steps of (a) providing a dose of a first reactant to a reaction chamber, (b) purging the reaction chamber, (c) flowing a second reactant to the reaction chamber, (d) igniting a plasma in the reaction chamber, and (e) extinguishing the plasma and purging the reaction chamber. As a result of the nature of precursor delivery/adsorption onto the substrate surface, a single cycle of a PEALD process deposits a monolayer of material. The operations may be repeated a number of times to deposit additional monolayers to reach a desired film thickness.
Various embodiments herein relate to methods and apparatus for forming silicon oxide films on semiconductor substrates. Certain embodiments employ a relatively high deposition temperature, a relatively high level of RF power, and a relatively long plasma exposure duration, as compared to conventional methods. In some cases, additional plasma treatments may be performed periodically during deposition. Further, a bilayer may be formed in some cases, the bottom layer being deposited at different conditions than the upper layer.
In one aspect of the disclosed embodiments, a method of depositing a silicon oxide film on a surface of a substrate in a single or multi-station reaction chamber is provided. The method may include (a) flowing a silicon-containing reactant in vapor phase into the reaction chamber under conditions allowing the silicon-containing reactant to adsorb onto the surface of the substrate; (b) after (a), flowing an oxygen-containing reactant in vapor phase into the reaction chamber, and exposing the surface of the substrate to plasma to drive a surface reaction between the silicon-containing reactant and the oxygen-containing reactant to form the silicon oxide film, where flowing the oxygen-containing reactant and exposing the surface of the substrate to plasma occur at least partially at the same time, where a temperature of the substrate is maintained between about 435-550° C. during (a) and (b), where the plasma is generated using a total RF power between about 2.1-3.6 Watts per square centimeter of substrate area, and where the surface of the substrate is exposed to the plasma in (b) for a duration between about 2-5 seconds; and (c) repeating (a) and (b) until the silicon oxide film reaches a target thickness.
In certain cases, the silicon oxide film forms in a recessed feature having an aspect ratio of about 10 or higher. The width of the recessed feature may be between about 2-100 μm, for example between about 5-50 μm, or between about 5-20 μm. The recessed feature may be a through-silicon-via in some cases. The recessed feature may also form a portion of a 3D-NAND structure.
Purge steps may be introduced at appropriate times. For instance, the method may include performing a post-reactant purge after the flow of the silicon-containing reactant has ceased and before the flow of the oxygen-containing reactant begins, and performing a post-plasma purge after exposing the surface of the substrate to plasma. The silicon-containing reactant may be flowed into the reaction chamber for a duration between about 0.2-1 second in (a). The post-reactant purge may have a duration between about 0.2-1 second. The oxygen-containing reactant may be flowed into the reaction chamber and the surface of the substrate may be exposed to plasma for a duration between about 0.1-0.5 seconds. In some cases, the silicon-containing reactant includes an amino substituted silane, and the oxygen-containing reactant includes at least one of oxygen, nitrous oxide, ozone, carbon monoxide, nitric oxide, nitrogen dioxide, sulfur oxide, sulfur dioxide, an oxygen-containing hydrocarbon, water, and mixtures thereof. In some cases the amino substituted silane may include BTBAS. Many other reactants may also be used. The pressure within the reaction chamber may be maintained between about 2-6 Torr during (a) and (b) in certain cases.
The film formed according to the disclosed embodiments is often a high quality film, as evidenced by relatively low wet etch rates. In some embodiments, the silicon oxide film exhibits a first wet etch rate at a field region proximate a top opening of the feature, a second wet etch rate at a top corner of the feature, a third wet etch rate at a middle of a sidewall of the feature, and a fourth wet etch rate at a bottom of the feature, where the first wet etch rate is equal to or greater than the third wet etch rate. The first wet etch rate may be equal to or greater than the second wet etch rate, which may be equal to or greater than the third wet etch rate, which may be equal to or greater than the fourth wet etch rate. In some cases, the first wet etch rate, second wet etch rate, third wet etch rate, and fourth wet etch rate do not differ from one another by more than about 15%.
The film formed according to the disclosed embodiments may also exhibit good electrical qualities. For instance, the silicon oxide film may have a breakdown voltage between about −7.6 and −12.7 MC/cm. The silicon oxide film may exhibit a flatband voltage that does not differ by more than about 1.3 V across the substrate.
As mentioned, the method may also include performing periodic plasma treatments. The plasma treatment may include generating a treatment plasma from a treatment plasma generation gas, and exposing the surface of the substrate to the treatment plasma generation gas for a duration between about 10-100 seconds. The treatment plasma may have the effect of densifying the film. In some cases the treatment plasma generation gas is oxygen, a mixture of oxygen and argon, or helium. Where a mixture of oxygen and argon are used, a ratio of oxygen:argon in the plasma treatment generation gas may be between about 0.5:1 and 2:1, as measured in SLM. The plasma generation gas may flow at a rate between about 5-20 SLM. A pressure within the reaction chamber may be maintained between about 2-6 Torr while the surface of the substrate is exposed to the treatment plasma. In some cases the treatment plasma may be generated using a total RF power between about 0.3-1.8 Watts per square centimeter of substrate area.
The embodiments herein also relate to cases where a bilayer is formed. For instance, the method may further include (d) after (c), flowing a second silicon-containing reactant in vapor phase into the reaction chamber under conditions allowing the second silicon-containing reactant to adsorb onto the surface of the substrate; (e) after (d), flowing a second oxygen-containing reactant in vapor phase into the reaction chamber, and exposing the surface of the substrate to a second plasma to drive a surface reaction between the second silicon-containing reactant and the second oxygen-containing reactant to form a secondary silicon oxide film, where flowing the second oxygen-containing reactant and exposing the surface of the substrate to the second plasma occur at least partially at the same time, where a temperature of the substrate is maintained below about 400° C. during (d) and (e), where the second plasma is generated using a total RF power between about 0.7-1.8 Watts per square centimeter of substrate area, the RF power being provided only at high frequency RF, where the surface of the substrate is exposed to the second plasma in (e) for a duration between about 0.5-1 second; and (f) repeating (d) and (e) until the secondary silicon oxide film reaches a second target thickness.
In another aspect of the disclosed embodiments, a method of forming a silicon oxide bilayer on a semiconductor substrate is provided, the method including: (a) forming a first layer of silicon oxide on the substrate at a first temperature through a first atomic layer deposition reaction involving a first plasma generated at a first RF power and periodically exposed to the substrate for a first duration, and (b) forming a second layer of silicon oxide on the first layer of silicon oxide at a second temperature through a second atomic layer deposition reaction, the first layer of silicon oxide and second layer of silicon oxide together forming the silicon oxide bilayer, where formation of the second layer of silicon oxide involves a second plasma generated at a second RF power and periodically exposed to the substrate for a second duration, where the first temperature is higher than the second temperature, where the first RF power is greater than the second RF power, where the first duration is greater than the second duration, and where the first layer of silicon oxide has a lower wet etch rate than the second layer of silicon oxide.
A thickness of the first bilayer of silicon oxide may represent about 20% or less of a total thickness of the silicon oxide bilayer. In certain embodiments the first RF power is between about 2.1-3.6 Watts per square centimeter of substrate area, and the first duration is between about 2-5 seconds. In these or other cases, the second RF power may be between about 0.7-1.8 Watts per square centimeter of substrate area, and the second duration may be between about 0.5-1 second. The first temperature may be between about 435-550° C. The second temperature may be about 400° C. or less.
In a further aspect of the disclosed embodiments, an apparatus for depositing silicon oxide film on a surface of a substrate is provided, the apparatus including: a reaction chamber; a plasma source for providing plasma in the reaction chamber; one or more inlets for providing a silicon-containing reactant and an oxygen-containing reactant to the reaction chamber; a substrate support for supporting the substrate within the reaction chamber; and a controller having instructions to: (a) flow the silicon-containing reactant in vapor phase into the reaction chamber under conditions allowing the silicon-containing reactant to adsorb onto the surface of the substrate; (b) after (a), flow the oxygen-containing reactant in vapor phase into the reaction chamber, and expose the surface of the substrate to plasma to drive a surface reaction between the silicon-containing reactant and the oxygen-containing reactant to form the silicon oxide film, where the controller has instructions to flow the oxygen-containing reactant and expose the surface of the substrate to plasma at least partially at the same time, where the controller has instructions to maintain a temperature of the substrate between about 435-550° C. during (a) and (b), where the controller has instructions to generate plasma using a total RF power between about 2.1-3.6 Watts per square centimeter of substrate area, and to generate the plasma using only high frequency RF, and where the controller has instructions to expose the surface of the substrate to the plasma in (b) for a duration between about 2-5 seconds; and (c) repeat (a) and (b) until the silicon oxide film reaches a target thickness.
In various embodiments, the controller may further have instructions to purge the reaction chamber after the flow of silicon-containing reactant has ceased and before the flow of oxygen-containing reactant begins, and to purge the reaction chamber after exposing the surface of the substrate to plasma. The controller may have instructions to flow the silicon-containing reactant into the reaction chamber for a duration between about 0.2-1 second in (a), purge the reaction chamber for a duration between about 0.2-1 second between (a) and (b), flow the oxygen-containing reactant into the reaction chamber and expose the surface of the substrate to plasma for a duration between about 0.5-1 second in (b), and to purge the reaction chamber for a duration between about 0.1-0.5 seconds after (b). The controller may also have instructions to maintain a pressure within the reaction chamber between about 2-6 Torr during (a) and (b).
The controller may further have instructions to expose the surface of the substrate to a plasma treatment by: generating a treatment plasma from a treatment plasma generation gas; and exposing the surface of the substrate to the treatment plasma for a duration between about 10-100 seconds to thereby densify the silicon oxide film. In some cases the controller may have instructions to generate the treatment plasma using a total RF power between about 0.3-1.8 Watts per square centimeter of substrate area.
In certain cases, the controller may have instructions to form a bilayer. For instance, the controller may further have instructions to: (d) after (c) flow a second silicon-containing reactant in vapor phase into the reaction chamber under conditions allowing the second silicon-containing reactant to adsorb onto the surface of the substrate; (e) after (d), flow a second oxygen-containing reactant in vapor phase into the reaction chamber, and expose the surface of the substrate to a second plasma to drive a surface reaction between the second silicon-containing reactant and the second oxygen-containing reactant to form a secondary silicon oxide film, where the controller has instructions to flow the second oxygen-containing reactant and expose the surface of the substrate to the second plasma at least partially at the same time, where the controller has instructions to maintain a temperature of the substrate below about 400° C. during (d) and (e), where the controller has instructions to generate the second plasma using a total RF power between about 0.7-1.8 Watts per square centimeter of substrate area, and using only high frequency RF, and where the controller has instructions to expose the surface of the substrate to the second plasma in (e) for a duration between about 0.5-1 second; and (f) repeat (d) and (e) until the secondary silicon oxide film reaches a second target thickness.
In yet a further aspect of the disclosed embodiments, An apparatus for forming a silicon oxide bilayer on a semiconductor substrate is provided, the apparatus including: a reaction chamber; a plasma source for providing plasma in the reaction chamber; one or more inlets for providing a silicon-containing reactant and an oxygen-containing reactant to the reaction chamber; a substrate support for supporting the substrate within the reaction chamber; and a controller having instructions to: (a) form a first layer of silicon oxide on the substrate at a first temperature through a first atomic layer deposition reaction involving a first plasma generated at a first RF power and periodically exposed to the substrate for a first duration, and (b) form a second layer of silicon oxide on the first layer of silicon oxide at a second temperature through a second atomic layer deposition reaction, the first layer of silicon oxide and second layer of silicon oxide together forming the silicon oxide bilayer, where formation of the second layer of silicon oxide involves a second plasma generated at a second RF power and periodically exposed to the substrate for a second duration, where the first temperature is higher than the second temperature, where the first RF power is greater than the second RF power, where the first duration is greater than the second duration, and where the first layer of silicon oxide has a lower wet etch rate than the second layer of silicon oxide.
The controller may have instructions to deposit the bilayer such that the first layer represents about 20% or less of a total thickness of the silicon oxide bilayer.
In another aspect of the disclosed embodiments, an apparatus for forming silicon oxide film on a semiconductor substrate is provided, the apparatus including a reaction chamber, a plasma source for providing plasma in the reaction chamber, one or more inlets for providing a silicon-containing reactant and an oxygen-containing reactant to the reaction chamber; a substrate support for supporting the substrate within the reaction chamber; and a controller having instructions to deposit the silicon oxide film on the substrate according to any of the methods disclosed herein.
These and other features will be described below with reference to the associated drawings.
In this application, the terms “semiconductor wafer,” “wafer,” “substrate,” “wafer substrate,” and “partially fabricated integrated circuit” are used interchangeably. One of ordinary skill in the art would understand that the term “partially fabricated integrated circuit” can refer to a silicon wafer during any of many stages of integrated circuit fabrication thereon. A wafer or substrate used in the semiconductor device industry typically has a diameter of 200 mm, or 300 mm, or 450 mm. The flow rates and power levels given herein relate to those used with a four station reactor having four 300 mm wafers therein. The flow rates and power levels scale linearly based on substrate area. The following detailed description assumes the invention is implemented on a wafer. However, the invention is not so limited. The work piece may be of various shapes, sizes, and materials. In addition to semiconductor wafers, other work pieces that may take advantage of this invention include various articles such as printed circuit boards and the like.
In the following description, numerous specific details are set forth in order to provide a thorough understanding of the presented embodiments. The disclosed embodiments may be practiced without some or all of these specific details. In other instances, well-known process operations have not been described in detail to not unnecessarily obscure the disclosed embodiments. While the disclosed embodiments will be described in conjunction with the specific embodiments, it will be understood that it is not intended to limit the disclosed embodiments.
Manufacture of semiconductor devices typically involves depositing one or more thin films on a planar or non-planar substrate in an integrated fabrication process. In some aspects of the integrated process it may be useful to deposit thin films that conform to substrate topography. One type of reaction that is useful in some cases involves chemical vapor deposition (CVD). In typical CVD processes, gas phase reactants are introduced into a reaction chamber simultaneously and undergo a gas-phase reaction. The reaction products deposit on the surface of the substrate. The reaction may be driven by plasma, in which case the process may be referred to as a plasma enhanced chemical vapor deposition (PECVD) reaction. As used herein, the term CVD is intended to include PECVD unless otherwise indicated. CVD processes have certain disadvantages that render them less appropriate in some contexts. For instance, mass transport limitations of CVD gas phase reactions may cause “bread-loafing” deposition effects that show thicker deposition at top surfaces (e.g., top surfaces of gate stacks) and thinner deposition at recessed surfaces (e.g., bottom corners of gate stacks). Further, because some die may have regions of differing device density, mass transport effects across the wafer surface may result in within-die and within-wafer thickness variations. These thickness variations can result in over-etching of some regions and under-etching of other regions, which can degrade device performance and die yield. Another problem related to CVD processes is that they are often unable to form conformal films in high aspect ratio features. This issue is increasingly problematic as device dimensions continue to shrink.
Another type of reaction that is useful in many cases is atomic layer deposition (ALD). Whereas CVD processes primarily employ gas phase reactions to quickly deposit material on a substrate surface, ALD processes primarily involve surface-mediated reactions that deposit material in a much slower, cyclic manner. One type of ALD process is a plasma enhanced atomic layer deposition (PEALD) process, where the reaction is driven by exposure to plasma. In ALD processes, the reactants are delivered in a non-overlapping cyclic manner to minimize or eliminate unwanted gas phase reactions. A typical ALD reaction involves (1) exposing a substrate in a reaction chamber to a first gas phase reactant (e.g., a silicon-containing reactant) and allowing the reactant to adsorb onto the substrate surface, (2) purging the reaction chamber (e.g., by applying vacuum to evacuate the chamber or by flowing an inert gas to sweep the first reactant out of the chamber), (3) exposing the substrate to a second gas phase reactant (e.g., an oxygen-containing reactant or nitrogen-containing reactant), (4) exposing the substrate to an energy source (e.g., plasma or heat) to drive a surface reaction between the first reactant and the second reactant, and (5) purging the reaction chamber again. These steps may be repeated to build a film of desired thickness. In various cases, steps (3) and (4) overlap, wholly or partially, such that the second reactant is delivered to the reaction chamber while the substrate is exposed to plasma. ALD processes are also sometimes referred to as conformal film deposition (CFD) processes, particularly where no purge (or an incomplete purge) is done between steps (3) and (4), or where steps (3) and (4) overlap in time. As used herein, the term ALD includes thermal ALD, PEALD, and CFD unless otherwise indicated.
Depending on the exposure time of the precursor dosing steps and the sticking coefficients of the precursors, each ALD cycle may deposit a film layer of, in one example, between about 0.5-3 Å thick.
Methods for forming films using ALD/CFD are described in the following U.S. patent applications, each of which is herein incorporated by reference in its entirety: U.S. patent application Ser. No. 13/084,399, filed on Apr. 11, 2011; U.S. patent application Ser. No. 13/953,616, filed Jul. 29, 2013; U.S. patent application Ser. No. 14/074,596, filed Nov. 7, 2013; and U.S. patent application Ser. No. 14/144,107, filed Dec. 30, 2013.
Conventional PEALD processes result in the deposition of conformal films having substantially uniform thickness. However, although the films are uniform in thickness, they may not be uniform in quality. In some cases, the film deposited on the sidewall of a recessed feature is of poorer quality than the film deposited in the field region near the top of the feature or at the bottom of the feature. This poor quality is evidenced by a higher wet etch rate of the film at the sidewalls compared to the film near the top or bottom of the feature. A high wet etch rate correlates to less dense, lower quality film.
Without wishing to be bound by theory or mechanism of action, it is believed that the difference in film quality between the sidewalls of a feature and other areas of a feature in conventional PEALD methods may arise due to ion directionality. When a substrate is exposed to plasma, ions present in the plasma travel in a substantially linear manner to hit the surface of the substrate. These ions may provide energy for converting the precursor material(s) to a high quality film. Because the feature is recessed and the ions travel substantially linearly, the number of ions impacting the substrate is much higher near the field region of a feature, as compared to the bottom and sidewalls. The sidewalls and bottom are effectively shadowed due to the geometry of the feature. This difference may act to selectively densify the film near the top of the feature, leaving a less dense film on the sidewalls and bottom (especially the sidewalls). Further, the energy delivered by ions hitting the sidewalls and bottom is lower than the energy delivered by ions hitting other portions of the feature, again due to the geometry of the recessed feature. This may lead to different reactions happening at the sidewalls than at other regions. Another factor may be the relative amount of ions and radicals present in the plasma. The reaction parameters disclosed herein can be used to help mitigate these effects and produce a film having more uniform characteristics.
The processes described herein are used to produce silicon oxide films. Unless otherwise clear from context, the term silicon oxide is intended to cover stoichiometric and non-stoichiometric solid compositions of primarily silicon and oxygen. Silicon oxide films may have various morphologies, including varying degrees of crystallinity, roughness, etc.
At operation 104, a dose of a first reactant is flowed into the reaction chamber. The first reactant may be introduced at a rate between about 1-2 mL/min (based on the pre-vaporization volume of the reactant, assuming delivery to four 300 mm diameter wafers). This corresponds to a flow rate between about 3.5-7.1 mL/min per square meter of substrate area. As used herein, substrate area is calculated as the area of a single side of a wafer based on the radius of the wafer (i.e., the area of a single 300 mm wafer is A=πr2=70,700 mm2, or about 707 cm2, or about 0.07 m2 and the total substrate area over four stations is about 2830 cm2, or about 0.28 m2). The substrate area is not calculated to include additional surface area introduced due to features present on the wafer. The flow rates may be scaled linearly for substrates of other sizes. The first reactant may be introduced along with an inert carrier gas such as Ar or N2. The flow rate of the carrier gas may be between about 5-10 SLM, which corresponds to a flow rate between about 17-36 SLM per square meter of substrate area. The duration over which the first reactant is introduced into the chamber may be less than about 1 second, for example between about 0.2-1 second. The reactant adsorbs onto the surface of the substrate, including in the recessed features, where applicable. Where the film being deposited contains silicon, the first reactant is typically a silicon-containing reactant.
Next, the reaction chamber is purged at operation 106. In some embodiments, the purge includes sweeping the reaction chamber with a non-reactive gas, for example Ar or N2. The non-reactive gas may be delivered in a burst push, for example between about 20-40 SLM, which corresponds to about 70-140 SLM per square meter of substrate area. Alternatively or in addition, the purge may include evacuating the reaction chamber by performing a pump down. In this case, the pressure in the reaction chamber is significantly lower during the pump down than during reactant delivery, for example. The purge may have a duration between about 0.2-1 seconds. The purpose of this purge operation 106 is to remove all or substantially all of the non-adsorbed first reactant from the reaction chamber. In some embodiments, the purge/sweep may be less complete, where only a portion of the first reactant is removed from the reaction chamber. Optimal purge conditions may depend on the desired film characteristics. Unless otherwise stated, a sweep or purge as described herein may be partial, complete or substantially complete. In certain implementations, this purge/sweep may not occur.
Next, at operation 108, a second reactant is flowed into the reaction chamber. The second reactant is generally an oxygen-containing reactant. The second reactant may flow at a rate between about 10-20 SLM, which corresponds to a flow rate between about 35-71 SLM per square meter of substrate area. The second reactant may flow over a period having a duration between about 0.5-1 second.
Each of the first and second reactants may also be a mix of reactants. In one example, the second reactant may include both oxygen and nitrous oxide. Where more than one reactant is delivered to the reaction chamber at the same time, the reactants may be mixed prior to delivery (e.g., in a separate mixing vessel), or after delivery (e.g., in the reaction chamber itself).
At operation 110, a plasma is ignited in the reaction chamber and exposed to the substrate surface. In various embodiments, operations 108 and 110 occur, at least partially (and sometimes wholly) at the same time. In one particular example, the second reactant is provided continuously. In other embodiments, operations 108 and 110 begin at the same time. In some cases, the second reactant may be pre-flowed into the reaction chamber at 108 before plasma ignition occurs at 110. In certain embodiments, the second reactant is flowed into the reaction chamber at 108, then swept/purged from the reaction chamber before plasma ignition occurs at operation 110. In various cases, however, this purge may not occur. The plasma exposure step is also sometimes referred to as a conversion step, and as mentioned, it may overlap with delivery of the second reactant. The plasma exposure step may occur over a duration between about 0.5-1 second, which is relatively short compared to certain disclosed embodiments. The plasma may be generated using RF power in some cases, for example between about 2,000-5,000 Watts total divided among four stations, each having a 300 mm wafer therein. This corresponds to a total RF plasma power between about 0.7-1.8 Watts per square centimeter of substrate area. This RF power is relatively low compared to certain disclosed embodiments. The frequency used to generate the plasma may include a low frequency (LF) component (e.g., about 250-450 kHz) and/or a high frequency (HF) component (e.g., about 13.56 MHz or about 27 MHz). In various cases only HF frequency is used.
Next, the plasma is extinguished and the reaction chamber is purged at operation 112. As mentioned with respect to the purge at operation 106, this may include sweeping and/or pumping down the reaction chamber. Where a sweep is used, the chamber may be swept with a non-reactive gas such as Ar or N2, which may flow at a rate between about 20-40 SLM, which corresponds to a flow rate between about 70-140 SLM per square meter of substrate area. The purge may have a duration between about 0.1-0.5 seconds in some cases. In certain cases this sweep/purge is not performed. Operations 104-112 may deposit a film having a thickness defined by the precursor adsorption characteristics (e.g., a monolayer or less of deposited material).
Next, at operation 114, the film thickness is monitored. If the film is sufficiently thick, the method 100 ceases and the substrate is ready for further processing. If the film is not yet sufficiently thick, the method 100 continues by repeating from operation 104. Additional iterations may then be performed to build the film to a desired thickness.
Where a multi-station reaction chamber is used, the substrate may travel through the different stations during deposition. The use of a multi-station reaction chamber is beneficial because it can help promote a high throughput and minimize costs. For instance, plasma generation equipment and plumbing lines can be shared between the multiple stations. Further, where multi-station reaction chambers are used, fewer pieces of processing equipment are required to achieve the same throughput, as each chamber can simultaneously process a number of substrates. Another advantage to multi-station reactors is that spatial non-uniformities can be minimized. Each station has certain non-uniformities that can affect the deposition results. Where a multi-station reaction chamber is used, the substrate may cycle through the different stations, and the non-uniformities from each station are balanced/minimized by the remaining stations. This cycling significantly helps improve wafer-to-wafer uniformity.
The multi-station reaction chamber may have two or more stations. In these or other cases, the reaction chamber may have about sixteen stations or less, for example about eight stations or less. In a particular example, four stations are used. A different substrate may be present at each station. The ALD cycles may be broken into phases, where the substrates transfer to a new station between each set of phases. Each phase includes a number of individual ALD cycles. In one example, about 2000 ALD cycles are performed on four different stations. The first 500 cycles may be performed in the first station, the next 500 cycles in the second station, the next 500 cycles in the third station, and the remaining 500 cycles may be performed in the fourth station, when considering a single substrate. Additional numbers of shorter phases may be used as well (e.g., 100 cycles in each phase/station). In this case the substrate may cycle through each station a number of times (e.g., at 2000 cycles total over four stations at 100 cycles per phase, each substrate will go through each station five times).
As indicated, the plasma characteristics can have a substantial effect on the deposited film. In many embodiments, the plasma is a capacitively coupled plasma. However, other types of plasma may also be used, for example inductively coupled plasmas. Various types of plasma generators may be used including RF, DC and microwave plasma generators. The plasma may be either a direct plasma (i.e., a plasma generated in the reaction chamber), or a remotely-generated plasma.
For context, some embodiments are described with reference to a “baseline process”, which generally follows the process and conditions presented for
In the baseline process, the wafer temperature is about 400° C. The pressure employed in the baseline process is about 5-6 Torr. The first reactant (silicon-containing reactant) is delivered at a flow rate of about 1-2 mL/min in Ar or N2 carrier gas at about 5-10 SLM, and for a duration of 0.2-1 seconds. The flow of the first reactant is measured based on the pre-vaporization volume of the reactant. The second reactant is an oxidant such as oxygen and/or nitrous oxide, which is delivered at a flow rate of about 10-20 SLM, and for a duration of 0.5-1 seconds. Further, during the conversion phase of the baseline process, high frequency RF power is provided to generate the plasma at 13.56 MHz and about 5000 Watts. The plasma is left on for a duration of 0.5-1 seconds.
Disclosed improvements on the baseline process include (a) increasing the deposition temperature during at least the conversion phase, (b) increasing the exposure time during the conversion phase, and/or (c) increasing the plasma power during the conversion phase. Processes falling within the scope of these improvements do not require the exact baseline conditions described above. For example, they may be practiced using alternative first and second reactants, with a range of pressures (e.g., about 0.1-20 Torr), and/or within a range of RF frequencies (e.g., about 1-50 MHz). The above ranges are provided for a 4-station PECVD chamber equipped for depositing films on 300 mm silicon wafers. The flow rates and powers may have to be scaled as appropriate for reactors of other sizes. Other variations on the baseline process are disclosed below with reference to
The method 200 begins at operation 202, where a substrate is received into a reaction chamber. As mentioned, the reaction chamber may have a single station or a plurality of stations. The substrate will frequently be patterned to have a number of recessed features therein. In other cases the substrate may be unpatterned/flat. The substrate may be maintained at a temperature between about 435-550° C., for example between about 450-550° C., or between about 500-550° C. This substrate temperature is relatively hot compared to baseline methods. The reaction chamber may be maintained at a pressure between about 2-7 Torr.
At operation 204, a dose of a first reactant is flowed into the reaction chamber. The first reactant may be introduced at a rate between about 1-2 mL/min (based on the pre-vaporization volume of the reactant, assuming a single 300 mm diameter wafer). This corresponds to a flow rate between about 3.5-7.1 mL/min per square meter of substrate area. The first reactant may be introduced along with an inert carrier gas such as Ar or N2. The flow rate of the carrier gas may be between about 5-10 SLM, which corresponds to a flow rate between about 17-36 SLM per square meter of substrate area. The duration over which the first reactant is introduced into the chamber may be less than about 1 second, for example between about 0.2-1 second. The first reactant is typically a silicon-containing reactant, which adsorbs onto the surface of the substrate.
Next, the reaction chamber is purged at operation 206. In some embodiments, the purge includes sweeping the reaction chamber with a non-reactive gas, for example Ar or N2. As in the baseline method, the non-reactive gas may be delivered in a burst push, for example between about 20-40 SLM, which corresponds to about 70-140 SLM per square meter of substrate area. Alternatively or in addition, the purge may include evacuating the reaction chamber by performing a pump down. In this case, the pressure in the reaction chamber is significantly lower during the pump down than during reactant delivery, for example. The purge may have a duration between about 0.2-1 seconds.
Next, at operation 208, a second reactant is flowed into the reaction chamber. The second reactant is typically an oxygen-containing reactant. The second reactant may flow at a rate between about 10-20 SLM, which corresponds to a flow rate between about 35-71 SLM per square meter of substrate area. The second reactant may flow over a period having a duration between about 0.5-1 second. As mentioned with respect to the baseline method, each of the first and second reactants may also be a mix of reactants.
At operation 210, a plasma is ignited in the reaction chamber and exposed to the substrate surface. In various embodiments, operations 208 and 210 occur, at least partially (and sometimes wholly) at the same time. Operations 208 and 210 may begin at the same time, or at different times. In some cases, the second reactant may be pre-flowed into the reaction chamber at 208 before plasma ignition occurs at 210. The plasma exposure step may occur over a duration between about 2-5 seconds, which is relatively long compared to the baseline methods. The plasma may be generated using RF power in some cases, for example between about 6,000-10,000 Watts total divided among four stations, each having a 300 mm wafer therein. This corresponds to a total RF plasma power between about 2.1-3.6 Watts per square centimeter of substrate area. This RF power is relatively high compared to certain disclosed embodiments. In various embodiments, the RF power used to generate the plasma includes only HF frequencies (e.g., 13.56 MHz or 27 MHz). In certain cases, the RF power is provided at about 13.56 MHz, without any other frequencies.
Next, the plasma is extinguished and the reaction chamber is purged at operation 212. As mentioned with respect to the purge at operation 206, this may include sweeping and/or pumping down the reaction chamber. Where a sweep is used, the chamber may be swept with a non-reactive gas such as Ar or N2, which may flow at a rate between about 20-40 SLM, which corresponds to a flow rate between about 70-140 SLM per square meter of substrate area. The purge may have a duration between about 0.1-0.5 seconds in some cases. In certain cases this sweep/purge may be optional, though the use of a post-plasma purge may help promote formation of high quality film. Operations 204-212 generally result in the deposition of a monolayer of material (or a saturated layer as determined by thermodynamics), though in certain embodiments, less than a monolayer of material may be deposited.
After the plasma is extinguished, an optional additional plasma treatment may be performed at operation 213. The plasma treatment may be undertaken to help promote complete oxidation and/or further densify the film. The plasma treatment may have the effect of eliminating dangling bonds (e.g., Si—H bonds) present on the film surface. As shown in the Experimental section, below, the plasma treatments promote formation of film having a lower wet etch rate, which correlates with higher quality film.
The plasma treatment is performed periodically. In certain cases, the additional plasma treatment is performed during each ALD cycle. However, this approach lengthens processing times and therefore lowers throughput. In certain implementations, a single plasma treatment can affect multiple layers of deposited material, so intermittent/periodic plasma treatments performed less frequently are sufficient. In some cases, the plasma treatment occurs once per every 5 or more cycles, for example once per every 10 or more cycles. In these or other cases, the plasma treatment may occur once per every 100 or less cycles, for example once per every 50 or less cycles. In a particular example the additional plasma treatment occurs about once per every 50 ALD cycles.
The gas used to generate the treatment plasma may be referred to as the treatment plasma generation gas. The treatment plasma generation gas may include oxygen, helium, and/or argon in some cases. In one example, substantially pure oxygen or substantially pure helium is used. In another example, a mixture of oxygen and argon is used. In this case, the relative volumetric flows of oxygen:argon may be between about 0.5:1 and 2:1. The flow rate of the treatment plasma generation gas may be between about 5-20 SLM, which corresponds to about 17-71 SLM per square meter of substrate area. The reaction chamber may be maintained at a pressure between about 2-6 Torr during the plasma treatment. Where the treatment plasma is generated through RF, the RF power may be between about 1,000-5,000 Watts total divided among four stations having 300 mm wafers. This corresponds to an RF power of about 0.3-1.8 Watts per square centimeter of substrate area. The frequency used to generate the plasma may include both LF and HF components. In certain cases the frequency may include only LF or only HF components.
The plasma treatment step occurs between ALD cycles. After the plasma is extinguished, the chamber may be purged (e.g., through a sweep and/or pump down) to push out any unwanted gas. This purge may be referred to as a pre-plasma treatment purge. The pre-plasma treatment purge may have a duration between about 5-30 seconds, for example about 20 seconds. Next, a line charge may be performed for a short period, between about 1-10 seconds (e.g., 3 seconds) to prime a gas delivery line with the treatment plasma generation gas. This may be done to stabilize the flow of the treatment plasma generation gas. After the line charge, a treatment plasma is ignited in the reaction chamber and the substrate is exposed to the treatment plasma for a duration between about 10-100 seconds, for example between about 15-60 seconds, or between about 20-35 seconds. In some embodiments, this additional periodic plasma treatment at operation 213 is omitted.
Next, at operation 214, the film thickness is monitored. If the film is sufficiently thick, the method 200 ceases and the substrate is ready for further processing. If the film is not yet sufficiently thick, the method 200 continues by repeating from operation 204. Additional iterations may then be performed to build the film to a desired thickness.
Where a multi-station reaction chamber is used, the substrates may travel through the different stations as described above.
The relatively high temperature, high RF power, long RF exposure duration, and periodic plasma treatments help promote formation of a dense, high quality film having a low wet etch rate and good electrical properties. For example, the wet etch rate of silicon oxide (in 300:1 BOE) may be between about 0.2-0.5 Å/second, for example between about 0.2-0.4 Å/second in some cases.
Films deposited according to the disclosed embodiments may have a dielectric constant between about 3.8-4.0. The film may have a BDV between about −7.6 and −12.7 MC/cm. The film may have a Vfb between about −4.7 and −10.4 V. The film may have a leakage of less than about 7.6E-10 at 1 MV/cm2, and/or a leakage of less than about 3.9E-10 at 2 MV/cm2. These properties may be the average properties, for instance averaged over three points on the wafer (near the edge, at the center, and at a point mid-way between the center and edge). In some cases the film may have a Vfb that varies by no more than about 1.3 V, for example by no more than about 1.3 V across the wafer.
As noted above, the first reactant is often a silicon-containing reactant and the second reactant (sometimes referred to as an auxiliary reactant) is often an oxygen-containing reactant.
Example silicon-containing reactants include, but are not limited to, silanes, halosilanes, and aminosilanes. A silane contains hydrogen and/or carbon groups, but does not contain a halogen. Examples of silanes are silane (SiH4), disilane (Si2H6), and organo silanes such as methylsilane, ethylsilane, isopropylsilane, t-butylsilane, dimethylsilane, diethylsilane, di-t-butylsilane, allylsilane, sec-butylsilane, thexylsilane, isoamylsilane, t-butyldisilane, di-t-butyldisilane, tetra-ethyl-ortho-silicate (also known as tetra-ethoxy-silane or TEOS) and the like. A halosilane contains at least one halogen group and may or may not contain hydrogens and/or carbon groups. Examples of halosilanes are iodosilanes, bromosilanes, chlorosilanes and fluorosilanes. Although halosilanes, particularly fluorosilanes, may form reactive halide species that can etch silicon materials, in certain embodiments described herein, the silicon-containing reactant is not present when a plasma is struck. Specific chlorosilanes are tetrachlorosilane (SiCl4), trichlorosilane (HSiCl3), dichlorosilane (H2SiCl2), monochlorosilane (ClSiH3), chloroallylsilane, chloromethylsilane, dichloromethylsilane, chlorodimethylsilane, chloroethylsilane, t-butylchlorosilane, di-t-butylchlorosilane, chloroisopropylsilane, chloro-sec-butylsilane, t-butyldimethylchlorosilane, thexyldimethylchlorosilane, and the like. An aminosilane includes at least one nitrogen atom bonded to a silicon atom, but may also contain hydrogens, oxygens, halogens and carbons. Examples of aminosilanes are mono-, di-, tri- and tetra-aminosilane (H3Si(NH2)4, H2Si(NH2)2, HSi(NH2)3 and Si(NH2)4, respectively), as well as substituted mono-, di-, tri- and tetra-aminosilanes, for example, t-butylaminosilane, methylaminosilane, tert-butylsilanamine, bis(tertiarybutylamino)silane (SiH2(NHC(CH3)3)2 (BTBAS), tert-butyl silylcarbamate, SiH(CH3)—(N(CH3)2)2, SiHCl—(N(CH3)2)2, (Si(CH3)2NH)3 and the like. A further example of an aminosilane is trisilylamine (N(SiH3)3). The silicon-containing reactant may also be a mixture of two or more of such reactants.
Examples of oxygen-containing reactants include oxygen, ozone, nitrous oxide, nitric oxide, nitrogen dioxide, carbon monoxide, carbon dioxide, sulfur monoxide, sulfur dioxide, water, oxygen-containing hydrocarbons (CxHyOz), etc. The oxygen-containing reactant may also be a mixture of any two or more of such reactants.
Other precursors, such as will be apparent to or readily discernible by those skilled in the art given the teachings provided herein, may also be used. The disclosed process window may be used to achieve a high quality, high density layer of silicon oxide film.
In some embodiments, the additional plasma treatment and/or the disclosed process window (using high power RF for relatively long plasma exposures, performed at relatively high temperatures), may produce certain adverse effects on the film. As compared to the conventional/baseline method, the film formed through the disclosed methods may suffer from somewhat high within-wafer non-uniformity. Further, the disclosed process window and related additional plasma treatment may reduce throughput due to the longer RF plasma exposure durations used during the conversion step and the time it takes to perform the additional plasma treatments.
These issues may be addressed by forming a “bilayer” in certain embodiments. The bilayer approach allows for formation of a high quality interface with underlying layers while maximizing within-wafer uniformity and throughput. In other words, the bilayer approach may be used to address certain drawbacks related to the disclosed process window, such that high throughput and high uniformity are maintained despite the relatively harsh processing conditions used to deposit a portion of the bilayer.
Where a bilayer approach is used, a bottom layer may be deposited according to the disclosed techniques utilizing one or more (or all) of a high temperature, high plasma power, long plasma exposure duration, and additional plasma treatments, as described with relation to
The method 250 begins at operation 252, where a bottom layer of film is deposited using a first set of ALD reaction conditions designed to create a high quality, dense film having a low wet etch rate. The reaction may proceed according to the method 200 of
The method 250 continues at operation 254, where a top layer of film is deposited using a second set of ALD reaction conditions designed to create a highly uniform film at a relatively higher throughput compared to the bottom layer of the bilayer. This portion of the deposition may proceed according to the method 100 of
It is expected that the disclosed embodiments will be beneficial in achieving uniform film quality in recessed features. However, the methods may also be used to deposit films on other types of substrates (e.g., flat substrates, or substrates having protruding features). The need for the improved sidewall quality and overall film uniformity may not be as great in the context of these types of non-recessed substrates.
In some embodiments, the substrate includes one or more recessed features having aspect ratios of about 10:1 or higher. In these or other cases, the aspect ratio of the feature may be about 30:1 or lower, for example about 25:1 or lower, or about 20:1 or lower. This ratio is defined as the depth:width of the recessed feature. In other cases, the aspect ratio of the features may be higher or lower than the disclosed values. Features having aspect ratios between about 10:1 and 20:1 are expected to see the greatest benefit from the disclosed embodiments, though even flat wafers may benefit as well. In some cases the width of the recessed feature may be between about 2-100 μm, for example between about 5-50 μm, or between about 5-20 μm.
The film formed according to the disclosed embodiments may have an average wet etch rate relative to thermally grown silicon oxide between about 1.2-1.6, for example between about 1.24-1.59 in some cases. Where the film is formed in a trench or other recessed feature, the average wet etch rate is calculated as the average of the wet etch rates at the top, top corner, middle portion of the sidewall, and bottom of the feature (i.e., these four WERs are averaged together). The middle portion of the sidewall may have a wet etch rate relative to thermally grown silicon oxide between about 1.1-1.5, for example between about 1.14-1.46 in some cases. The ratio between the WER at the middle portion of the sidewall of the feature and the WER at the top of the feature (WERsidewall/WERtop) may be between about 1.05-1.1, for example between about 1.06-1.09 in some cases. In other cases, this ratio (WERsidewall/WERtop) is below about 1, for example between about 0.9-1, or between about 0.9-0.95. After etching (e.g., in 300:1 BOE, 150 seconds), the top portion of the feature may have at least about 77% remaining, the top corner of the feature may have at least about 43% remaining, the middle portion of the sidewall may have at least about 78% remaining, and/or the bottom portion of the feature may have at least about 84% remaining, when considering the remaining film thickness compared to the initial film thickness.
Apparatus
A suitable apparatus for performing the disclosed methods typically includes hardware for accomplishing the process operations and a system controller having instructions for controlling process operations in accordance with the present embodiments. For example, in some embodiments, the hardware may include one or more PEALD process stations included in a process tool having a controller.
Within the reactor, a wafer pedestal 318 supports a substrate 316. The pedestal typically includes a chuck, a fork, and/or lift pins to hold and transfer the substrate during and between the deposition and/or plasma treatment reactions. The chuck may be an electrostatic chuck, a mechanical chuck or various other types of chuck as are available for use in the industry and/or research.
The process gases are introduced via inlet 312. Multiple source gas lines 310 are connected to manifold 308. The gases may be premixed or not. Appropriate valving and mass flow control mechanisms are employed to ensure that the correct gases are delivered during the deposition and plasma treatment phases of the process. In the case that the chemical precursor(s) are delivered in liquid form, liquid flow control mechanisms are employed. The liquid is then vaporized and mixed with other process gases during its transportation in a manifold heated above its vaporization point before reaching the deposition chamber.
Process gases exit chamber 300 via an outlet 322. A vacuum pump 326 (e.g., a one or two stage mechanical dry pump and/or a turbomolecular pump) typically draws process gases out and maintains a suitably low pressure within the reactor by a close loop controlled flow restriction device, such as a throttle valve or a pendulum valve.
The invention may be implemented on a multi-station or single station tool. In specific embodiments, the 300 mm Novellus Vector™ tool having a 4-station deposition scheme or the 200 mm Sequel™ tool having a 6-station deposition scheme are used. The embodiments may also be practiced on apparatus designed to process 450 mm substrates or other sized substrates. It is possible to index the wafers after every deposition and/or post-deposition plasma treatment until all the required depositions and treatments are completed, or multiple depositions and treatments can be conducted at a single station before indexing the wafer. It has been shown that film stress is the same in either case. However, conducting multiple depositions/treatments on one station is substantially faster than indexing following each deposition and/or treatment.
The depicted processing chamber 2414 comprises four process stations, numbered from 1 to 4 in the embodiment shown in
In some embodiments, system controller 2450 controls all of the activities of process tool 2400. System controller 2450 executes system control software 2458 stored in mass storage device 2454, loaded into memory device 2456, and executed on processor 2452. System control software 2458 may include instructions for controlling the timing, mixture of gases, chamber and/or station pressure, chamber and/or station temperature, purge conditions and timing, wafer temperature, RF power levels, RF frequencies, substrate, pedestal, chuck and/or susceptor position, and other parameters of a particular process performed by process tool 2400. System control software 2458 may be configured in any suitable way. For example, various process tool component subroutines or control objects may be written to control operation of the process tool components necessary to carry out various process tool processes in accordance with the disclosed methods. System control software 2458 may be coded in any suitable computer readable programming language.
In some embodiments, system control software 2458 may include input/output control (IOC) sequencing instructions for controlling the various parameters described above. For example, each phase of a PEALD process may include one or more instructions for execution by system controller 2450. The instructions for setting process conditions for a PEALD process phase may be included in a corresponding PEALD recipe phase. In some embodiments, the PEALD recipe phases may be sequentially arranged, so that all instructions for a PEALD process phase are executed concurrently with that process phase.
Other computer software and/or programs stored on mass storage device 2454 and/or memory device 2456 associated with system controller 2450 may be employed in some embodiments. Examples of programs or sections of programs for this purpose include a substrate positioning program, a process gas control program, a pressure control program, a heater control program, and a plasma control program.
A substrate positioning program may include program code for process tool components that are used to load the substrate onto pedestal 2418 and to control the spacing between the substrate and other parts of process tool 2400.
A process gas control program may include code for controlling gas composition and flow rates and optionally for flowing gas into one or more process stations prior to deposition in order to stabilize the pressure in the process station. A pressure control program may include code for controlling the pressure in the process station by regulating, for example, a throttle valve in the exhaust system of the process station, a gas flow into the process station, etc.
A heater control program may include code for controlling the current to a heating unit that is used to heat the substrate. Alternatively, the heater control program may control delivery of a heat transfer gas (such as helium) to the substrate. The heater control program may include instructions to maintain the temperature of the substrate within any of the disclosed ranges.
A plasma control program may include code for setting RF power levels and frequencies applied to the process electrodes in one or more process stations, for example using any of the RF power levels disclosed herein. The plasma control program may also include code for controlling the duration of each plasma exposure as disclosed above.
In some embodiments, there may be a user interface associated with system controller 2450. The user interface may include a display screen, graphical software displays of the apparatus and/or process conditions, and user input devices such as pointing devices, keyboards, touch screens, microphones, etc.
In some embodiments, parameters adjusted by system controller 2450 may relate to process conditions. Non-limiting examples include process gas composition and flow rates, temperature, pressure, plasma conditions (such as RF power levels, frequency, and exposure time), etc. These parameters may be provided to the user in the form of a recipe, which may be entered utilizing the user interface.
Signals for monitoring the process may be provided by analog and/or digital input connections of system controller 2450 from various process tool sensors. The signals for controlling the process may be output on the analog and digital output connections of process tool 2400. Non-limiting examples of process tool sensors that may be monitored include mass flow controllers, pressure sensors (such as manometers), thermocouples, etc. Appropriately programmed feedback and control algorithms may be used with data from these sensors to maintain process conditions.
System controller 2450 may provide program instructions for implementing the above-described deposition processes. The program instructions may control a variety of process parameters, such as DC power level, RF power level, RF frequency, RF plasma exposure duration, pressure, temperature, etc. The instructions may control the parameters to operate in-situ deposition of film stacks according to various embodiments described herein.
The various hardware and method embodiments described above may be used in conjunction with lithographic patterning tools or processes, for example, for the fabrication or manufacture of semiconductor devices, displays, LEDs, photovoltaic panels and the like. Typically, though not necessarily, such tools/processes will be used or conducted together in a common fabrication facility.
Lithographic patterning of a film typically comprises some or all of the following steps, each step enabled with a number of possible tools: (1) application of photoresist on a workpiece, e.g., a substrate having a silicon nitride film formed thereon, using a spin-on or spray-on tool; (2) curing of photoresist using a hot plate or furnace or other suitable curing tool; (3) exposing the photoresist to visible or UV or x-ray light with a tool such as a wafer stepper; (4) developing the resist so as to selectively remove resist and thereby pattern it using a tool such as a wet bench or a spray developer; (5) transferring the resist pattern into an underlying film or workpiece by using a dry or plasma-assisted etching tool; and (6) removing the resist using a tool such as an RF or microwave plasma resist stripper. In some embodiments, an ashable hard mask layer (such as an amorphous carbon layer) and another suitable hard mask (such as an antireflective layer) may be deposited prior to applying the photoresist.
It is to be understood that the configurations and/or approaches described herein are exemplary in nature, and that these specific embodiments or examples are not to be considered in a limiting sense, because numerous variations are possible. The specific routines or methods described herein may represent one or more of any number of processing strategies. As such, various acts illustrated may be performed in the sequence illustrated, in other sequences, in parallel, or in some cases omitted. Likewise, the order of the above described processes may be changed.
The subject matter of the present disclosure includes all novel and nonobvious combinations and sub-combinations of the various processes, systems and configurations, and other features, functions, acts, and/or properties disclosed herein, as well as any and all equivalents thereof.
Experimental results have shown that the disclosed process window may be used to deposit high quality films having low wet etch rates and good electrical properties.
Not all conditions were tested at each temperature. As shown in the figure, increasing substrate temperature leads to lower wet etch rates in the resulting film. For instance, compared to the baseline conventional process at 400° C., the 435° C. cases show about a 4% reduction to the wet etch rate, the 460° C. cases show about an 8% reduction to the wet etch rate, and the 495° C. case shows about a 13% reduction to the wet etch rate. This correlation suggests that higher substrate temperatures may result in higher quality films.
Additional films were formed and tested using the disclosed optional plasma treatments. Each tested plasma treatment was performed once per every 50 ALD cycles, for a duration of about 30 seconds, at a pressure of about 4 Torr, using an RF power of about 2500 Watts divided among four stations, each station having a 300 mm wafer therein. A first plasma treatment involved exposing the substrate to helium plasma. A second plasma treatment involved exposing the substrate to oxygen plasma. A third plasma treatment involved exposing the substrate to an oxygen/argon plasma (oxygen:argon delivered at a 2:1 ratio). The films treated with the plasma treatments show slightly lower compressive stress, and lower wet etch rates. The film treated with the helium plasma also showed a higher refractive index (RI), which indicates a denser film.
Another film was deposited as a bilayer. The bottom layer the bilayer was about 150 Å thick, deposited at high RF power (6000 W among four stations), long RF exposure (2 seconds), and high temperature (495° C.), with a helium plasma treatment every 50 ALD cycles. The top layer of the bilayer was about 850 Å thick, deposited according to the baseline process window, without additional plasma treatments. The bilayer showed very good results in terms of wet etch rate, electrical properties, and uniformity (wafer-to-wafer and within-wafer). The uniformity in the bilayer case was improved compared to cases where the entire film was deposited according to the disclosed process window.
Fourier transform infrared spectroscopy (FTIR) was performed on many of the deposited films. For all cases, the films advantageously show no signal relating to OH bonds (which would be found at a wavenumber of about 3000 cm−1). This suggests that the disclosed plasma treatments do not degrade the film. Further, the data show that the signal relating to Si—O—Si bonds (stretching) is enhanced where higher temperatures and/or longer RF exposure times are used. The signal enhancement is evidenced by an increase in absorbance and peak wavenumber. The films that were deposited using the optional plasma treatments were also subjected to FTIR analysis. While the oxygen and oxygen/argon plasma treatments did show an impact on the FTIR results, the helium plasma treatment reduces the Si—O—Si signal.
Each film was also tested for its electrical properties including breakdown voltage (BDV), flatband voltage (Vfb), dielectric constant (k), and leakage. Each film was tested at three points on the wafer (edge, center, and a point between the edge and center). The electrical properties (BDV, Vfb and leakage), as well as the within-wafer uniformity of the electrical properties, improve with higher temperatures and longer RF exposure durations. The oxygen and oxygen/argon plasma treatments improved the leakage and within-wafer electrical uniformity, as evidenced by a tight distribution of Vfb across the wafer. The oxygen/argon plasma treatment resulted in a film having excellent uniformity of electrical properties. The film formed with periodic helium plasma treatments showed slightly worse electrical properties, with a lower BDV, higher leakage and larger range of Vfb across the wafer as compared to the other plasma treatments.
Table 2 describes the etching results related to the test wafer 700 shown in
The WER at the sidewall was very high compared to the WER at other portions of the film. The top portion of the film showed the lowest wet etch rate, followed by the bottom portion, then the top corner, and finally the sidewall.
Table 3 describes the etching results related to the test wafer 710 shown in
In this example, the wet etch rate was much more uniform at the different portions of the trench 714 compared to the results seen in trench 704 of
Table 4 describes the etching results related to the test wafer 720 shown in
As shown in
Table 5 describes the etching results related to the test wafer 720 shown in
In this example, the top corners of the silicon oxide film 732 showed signs of sputtering during deposition, though to a lesser extent than the silicon oxide film 722 of
Number | Name | Date | Kind |
---|---|---|---|
4500563 | Ellenberger et al. | Feb 1985 | A |
5223443 | Chinn et al. | Jun 1993 | A |
5496608 | Matsuda et al. | Mar 1996 | A |
5593914 | Evans, Jr. et al. | Jan 1997 | A |
5670432 | Tsai | Sep 1997 | A |
5856003 | Chiu | Jan 1999 | A |
5874368 | Laxman et al. | Feb 1999 | A |
5932286 | Beinglass et al. | Aug 1999 | A |
6069058 | Hong | May 2000 | A |
6100202 | Lin et al. | Aug 2000 | A |
6218293 | Kraus et al. | Apr 2001 | B1 |
6270572 | Kim et al. | Aug 2001 | B1 |
6346741 | Van Buskirk et al. | Feb 2002 | B1 |
6391803 | Kim et al. | May 2002 | B1 |
6416822 | Chiang et al. | Jul 2002 | B1 |
6428859 | Chiang et al. | Aug 2002 | B1 |
6468924 | Lee et al. | Oct 2002 | B2 |
6509601 | Lee et al. | Jan 2003 | B1 |
6528430 | Kwan et al. | Mar 2003 | B2 |
6551893 | Zheng et al. | Apr 2003 | B1 |
6569501 | Chiang et al. | May 2003 | B2 |
6576053 | Kim et al. | Jun 2003 | B1 |
6602784 | Sneh | Aug 2003 | B2 |
6632478 | Gaillard et al. | Oct 2003 | B2 |
6645574 | Lee et al. | Nov 2003 | B1 |
6689220 | Nguyen | Feb 2004 | B1 |
6723595 | Park | Apr 2004 | B2 |
6730614 | Lim et al. | May 2004 | B1 |
6743738 | Todd | Jun 2004 | B2 |
6756318 | Nguyen et al. | Jun 2004 | B2 |
6765303 | Krivokapic et al. | Jul 2004 | B1 |
6809421 | Hayasaka et al. | Oct 2004 | B1 |
6828218 | Kim et al. | Dec 2004 | B2 |
6835417 | Saenger et al. | Dec 2004 | B2 |
6861356 | Matsuse et al. | Mar 2005 | B2 |
6884466 | Kaloyeros et al. | Apr 2005 | B2 |
6930058 | Hill et al. | Aug 2005 | B2 |
6930060 | Chou et al. | Aug 2005 | B2 |
6943092 | Kim | Sep 2005 | B2 |
6962876 | Ahn et al. | Nov 2005 | B2 |
6987240 | Jennings et al. | Jan 2006 | B2 |
7001844 | Chakravarti et al. | Feb 2006 | B2 |
7041335 | Chung | May 2006 | B2 |
7077904 | Cho et al. | Jul 2006 | B2 |
7081271 | Chung et al. | Jul 2006 | B2 |
7109129 | Papasouliotis | Sep 2006 | B1 |
7115166 | Vaartstra et al. | Oct 2006 | B2 |
7115528 | Vaartstra et al. | Oct 2006 | B2 |
7122222 | Xiao et al. | Oct 2006 | B2 |
7122464 | Vaartstra | Oct 2006 | B2 |
7125815 | Vaartstra | Oct 2006 | B2 |
7132353 | Xia et al. | Nov 2006 | B1 |
7141278 | Koh et al. | Nov 2006 | B2 |
7148155 | Tarafdar et al. | Dec 2006 | B1 |
7151039 | Lee et al. | Dec 2006 | B2 |
7172792 | Wang et al. | Feb 2007 | B2 |
7176084 | Lee et al. | Feb 2007 | B2 |
7205187 | Leith et al. | Apr 2007 | B2 |
7223649 | Oh et al. | May 2007 | B2 |
7235484 | Nguyen et al. | Jun 2007 | B2 |
7241686 | Marcadal et al. | Jul 2007 | B2 |
7244668 | Kim | Jul 2007 | B2 |
7250083 | Sneh | Jul 2007 | B2 |
7259050 | Chen et al. | Aug 2007 | B2 |
7261919 | Mehregany et al. | Aug 2007 | B2 |
7294582 | Haverkort et al. | Nov 2007 | B2 |
7297641 | Todd et al. | Nov 2007 | B2 |
7300885 | Hasebe et al. | Nov 2007 | B2 |
7314835 | Ishizaka et al. | Jan 2008 | B2 |
7341959 | Brcka | Mar 2008 | B2 |
7351668 | Chou et al. | Apr 2008 | B2 |
7361538 | Luan et al. | Apr 2008 | B2 |
7361611 | Chakravarti et al. | Apr 2008 | B2 |
7390743 | Shin | Jun 2008 | B2 |
7393561 | Paranjpe | Jul 2008 | B2 |
7399388 | Moghadam et al. | Jul 2008 | B2 |
7419888 | Yang et al. | Sep 2008 | B2 |
7435454 | Brcka | Oct 2008 | B2 |
7435684 | Lang et al. | Oct 2008 | B1 |
7462571 | Hasebe et al. | Dec 2008 | B2 |
7482247 | Papasouliotis et al. | Jan 2009 | B1 |
7488694 | Kim et al. | Feb 2009 | B2 |
7507676 | Chou et al. | Mar 2009 | B2 |
7510984 | Saito et al. | Mar 2009 | B2 |
7521331 | Park et al. | Apr 2009 | B2 |
7524762 | Marcadal et al. | Apr 2009 | B2 |
7544615 | Vaartstra | Jun 2009 | B2 |
7572052 | Ravi et al. | Aug 2009 | B2 |
7592231 | Cheng et al. | Sep 2009 | B2 |
7595010 | Chakravarti et al. | Sep 2009 | B2 |
7601648 | Chua et al. | Oct 2009 | B2 |
7615438 | Ahn et al. | Nov 2009 | B2 |
7615449 | Chung et al. | Nov 2009 | B2 |
7622369 | Lee et al. | Nov 2009 | B1 |
7622383 | Kim et al. | Nov 2009 | B2 |
7629267 | Wan et al. | Dec 2009 | B2 |
7632757 | Matsuura | Dec 2009 | B2 |
7633125 | Lu et al. | Dec 2009 | B2 |
7638170 | Li | Dec 2009 | B2 |
7645484 | Ishizaka | Jan 2010 | B2 |
7651729 | Kim et al. | Jan 2010 | B2 |
7651730 | Hasebe | Jan 2010 | B2 |
7651953 | Todd et al. | Jan 2010 | B2 |
7651959 | Fukazawa et al. | Jan 2010 | B2 |
7682657 | Sherman | Mar 2010 | B2 |
7687409 | Ahn et al. | Mar 2010 | B2 |
7713592 | Nguyen et al. | May 2010 | B2 |
7758920 | Hasebe et al. | Jul 2010 | B2 |
7776733 | Hasegawa | Aug 2010 | B2 |
7790633 | Tarafdar et al. | Sep 2010 | B1 |
7825039 | Takahashi et al. | Nov 2010 | B2 |
7906168 | Hasebe et al. | Mar 2011 | B2 |
7919416 | Lee et al. | Apr 2011 | B2 |
7923068 | Dickey et al. | Apr 2011 | B2 |
7923378 | Hasebe et al. | Apr 2011 | B2 |
7959985 | Ishizaka et al. | Jun 2011 | B2 |
7964241 | Hasebe et al. | Jun 2011 | B2 |
7964513 | Todd et al. | Jun 2011 | B2 |
7972980 | Lee et al. | Jul 2011 | B2 |
7981473 | Kim et al. | Jul 2011 | B2 |
7989365 | Park et al. | Aug 2011 | B2 |
8034673 | Kadonaga et al. | Oct 2011 | B2 |
8080290 | Hasebe et al. | Dec 2011 | B2 |
8101531 | Li et al. | Jan 2012 | B1 |
8119424 | Mather et al. | Feb 2012 | B2 |
8119544 | Hasebe et al. | Feb 2012 | B2 |
8133797 | van Schravendijk et al. | Mar 2012 | B2 |
8178448 | Nodera et al. | May 2012 | B2 |
8227032 | Dussarrat et al. | Jul 2012 | B2 |
8257789 | Matsunaga et al. | Sep 2012 | B2 |
8278224 | Mui et al. | Oct 2012 | B1 |
8334218 | Van Nooten et al. | Dec 2012 | B2 |
8357619 | Hasebe et al. | Jan 2013 | B2 |
8366953 | Kohno et al. | Feb 2013 | B2 |
8383525 | Raisanen et al. | Feb 2013 | B2 |
8394466 | Hong et al. | Mar 2013 | B2 |
8524612 | Li et al. | Sep 2013 | B2 |
8592328 | Hausmann et al. | Nov 2013 | B2 |
8633050 | Pierreux | Jan 2014 | B2 |
8637411 | Swaminathan et al. | Jan 2014 | B2 |
8647993 | Lavoie et al. | Feb 2014 | B2 |
8669185 | Onizawa et al. | Mar 2014 | B2 |
8728955 | LaVoie et al. | May 2014 | B2 |
8728956 | LaVoie et al. | May 2014 | B2 |
8956983 | Swaminathan et al. | Feb 2015 | B2 |
8999859 | Swaminathan et al. | Apr 2015 | B2 |
9076646 | Sims et al. | Jul 2015 | B2 |
9214334 | Swaminathan et al. | Dec 2015 | B2 |
9230800 | Lavoie et al. | Jan 2016 | B2 |
9257274 | Kang et al. | Feb 2016 | B2 |
9287113 | Kang et al. | Mar 2016 | B2 |
9355839 | Swaminathan et al. | May 2016 | B2 |
9355886 | Swaminathan et al. | May 2016 | B2 |
9373500 | Swaminathan et al. | Jun 2016 | B2 |
9502238 | Danek et al. | Nov 2016 | B2 |
9564312 | Henri et al. | Feb 2017 | B2 |
9570274 | Swaminathan et al. | Feb 2017 | B2 |
9570290 | Swaminathan et al. | Feb 2017 | B2 |
9611544 | Lavoie et al. | Apr 2017 | B2 |
20020076507 | Chiang et al. | Jun 2002 | A1 |
20030008070 | Seutter et al. | Jan 2003 | A1 |
20030024477 | Okuda et al. | Feb 2003 | A1 |
20030143839 | Raaijmakers et al. | Jul 2003 | A1 |
20030200917 | Vaartstra | Oct 2003 | A1 |
20040033698 | Lee et al. | Feb 2004 | A1 |
20040043633 | Vaartstra | Mar 2004 | A1 |
20040053515 | Comita et al. | Mar 2004 | A1 |
20040121164 | Iacovangelo et al. | Jun 2004 | A1 |
20040219746 | Vaartstra et al. | Nov 2004 | A1 |
20040231799 | Lee et al. | Nov 2004 | A1 |
20050042865 | Cabral et al. | Feb 2005 | A1 |
20050079661 | Cho et al. | Apr 2005 | A1 |
20050109276 | Iyer et al. | May 2005 | A1 |
20050118837 | Todd et al. | Jun 2005 | A1 |
20050159017 | Kim et al. | Jul 2005 | A1 |
20050181535 | Yun et al. | Aug 2005 | A1 |
20050184397 | Gates et al. | Aug 2005 | A1 |
20050196977 | Saito et al. | Sep 2005 | A1 |
20050208718 | Lim et al. | Sep 2005 | A1 |
20050230047 | Collins et al. | Oct 2005 | A1 |
20050233553 | Kountz et al. | Oct 2005 | A1 |
20050260347 | Narwankar et al. | Nov 2005 | A1 |
20050276099 | Horng et al. | Dec 2005 | A1 |
20050287775 | Hasebe et al. | Dec 2005 | A1 |
20060030148 | Seutter et al. | Feb 2006 | A1 |
20060084283 | Paranjpe et al. | Apr 2006 | A1 |
20060088985 | Haverkort et al. | Apr 2006 | A1 |
20060165890 | Kaushal et al. | Jul 2006 | A1 |
20060199357 | Wan et al. | Sep 2006 | A1 |
20060228868 | Ahn et al. | Oct 2006 | A1 |
20060286774 | Singh et al. | Dec 2006 | A1 |
20060286776 | Ranish et al. | Dec 2006 | A1 |
20060286818 | Wang et al. | Dec 2006 | A1 |
20070010071 | Matsuura | Jan 2007 | A1 |
20070065576 | Singh et al. | Mar 2007 | A1 |
20070087574 | Gupta et al. | Apr 2007 | A1 |
20070087581 | Singh et al. | Apr 2007 | A1 |
20070116887 | Faguet | May 2007 | A1 |
20070134942 | Ahn et al. | Jun 2007 | A1 |
20070137572 | Matsuura et al. | Jun 2007 | A1 |
20070145483 | Ono | Jun 2007 | A1 |
20070167028 | Chou et al. | Jul 2007 | A1 |
20070215036 | Park et al. | Sep 2007 | A1 |
20070218701 | Shimizu et al. | Sep 2007 | A1 |
20070231487 | Ishizaka | Oct 2007 | A1 |
20070232082 | Balseanu et al. | Oct 2007 | A1 |
20070251444 | Gros-Jean et al. | Nov 2007 | A1 |
20070259110 | Mahajani et al. | Nov 2007 | A1 |
20080014759 | Chua et al. | Jan 2008 | A1 |
20080038936 | Todd et al. | Feb 2008 | A1 |
20080063791 | Hasebe et al. | Mar 2008 | A1 |
20080075881 | Won et al. | Mar 2008 | A1 |
20080081470 | Clark | Apr 2008 | A1 |
20080087890 | Ahn et al. | Apr 2008 | A1 |
20080123394 | Lee et al. | May 2008 | A1 |
20080131601 | Kim et al. | Jun 2008 | A1 |
20080138996 | Nishizuka | Jun 2008 | A1 |
20080139003 | Pirzada et al. | Jun 2008 | A1 |
20080213479 | Chou et al. | Sep 2008 | A1 |
20080242116 | Clark | Oct 2008 | A1 |
20080274302 | Hasebe et al. | Nov 2008 | A1 |
20080311760 | Nodera et al. | Dec 2008 | A1 |
20080317972 | Hendriks et al. | Dec 2008 | A1 |
20090018668 | Galbraith | Jan 2009 | A1 |
20090039349 | Honda | Feb 2009 | A1 |
20090041952 | Yoon et al. | Feb 2009 | A1 |
20090065896 | Hwang et al. | Mar 2009 | A1 |
20090075490 | Dussarrat | Mar 2009 | A1 |
20090148625 | Yeom et al. | Jun 2009 | A1 |
20090155606 | Yoon et al. | Jun 2009 | A1 |
20090163012 | Clark et al. | Jun 2009 | A1 |
20090191722 | Hasebe et al. | Jul 2009 | A1 |
20090203197 | Hanawa et al. | Aug 2009 | A1 |
20090208880 | Nemani et al. | Aug 2009 | A1 |
20090278224 | Kim et al. | Nov 2009 | A1 |
20100022099 | Van Nooten et al. | Jan 2010 | A1 |
20100025824 | Chen et al. | Feb 2010 | A1 |
20100051578 | Chang et al. | Mar 2010 | A1 |
20100096688 | Balseanu et al. | Apr 2010 | A1 |
20100099236 | Kwon et al. | Apr 2010 | A1 |
20100099271 | Hausmann et al. | Apr 2010 | A1 |
20100102417 | Ganguli et al. | Apr 2010 | A1 |
20100124618 | Kobayashi et al. | May 2010 | A1 |
20100124621 | Kobayashi et al. | May 2010 | A1 |
20100136260 | Matsunaga et al. | Jun 2010 | A1 |
20100136313 | Shimizu et al. | Jun 2010 | A1 |
20100167555 | Maula et al. | Jul 2010 | A1 |
20100221925 | Lee et al. | Sep 2010 | A1 |
20100255218 | Oka et al. | Oct 2010 | A1 |
20100304574 | Nodera et al. | Dec 2010 | A1 |
20100310791 | Shimazu et al. | Dec 2010 | A1 |
20110003445 | Murata et al. | Jan 2011 | A1 |
20110014795 | Lee et al. | Jan 2011 | A1 |
20110014796 | Hayashi | Jan 2011 | A1 |
20110014798 | Mallick et al. | Jan 2011 | A1 |
20110042744 | Cheng et al. | Feb 2011 | A1 |
20110064969 | Chen et al. | Mar 2011 | A1 |
20110086516 | Lee et al. | Apr 2011 | A1 |
20110124187 | Afzali-Ardakani et al. | May 2011 | A1 |
20110139176 | Cheung et al. | Jun 2011 | A1 |
20110143548 | Cheung et al. | Jun 2011 | A1 |
20110151142 | Seamons et al. | Jun 2011 | A1 |
20110151246 | Ramon Moreno et al. | Jun 2011 | A1 |
20110151674 | Tang et al. | Jun 2011 | A1 |
20110151678 | Ashtiani et al. | Jun 2011 | A1 |
20110159202 | Matsushita et al. | Jun 2011 | A1 |
20110198756 | Thenappan et al. | Aug 2011 | A1 |
20110201210 | Sato et al. | Aug 2011 | A1 |
20110215445 | Yang et al. | Sep 2011 | A1 |
20110256726 | LaVoie et al. | Oct 2011 | A1 |
20110256734 | Hausmann et al. | Oct 2011 | A1 |
20110298099 | Lee et al. | Dec 2011 | A1 |
20110309475 | Lee | Dec 2011 | A1 |
20120009802 | LaVoie et al. | Jan 2012 | A1 |
20120009803 | Jung et al. | Jan 2012 | A1 |
20120021252 | Lee | Jan 2012 | A1 |
20120028454 | Swaminathan et al. | Feb 2012 | A1 |
20120028469 | Onizawa et al. | Feb 2012 | A1 |
20120058282 | Hong et al. | Mar 2012 | A1 |
20120077349 | Li et al. | Mar 2012 | A1 |
20120108079 | Mahajani | May 2012 | A1 |
20120113672 | Dubrow et al. | May 2012 | A1 |
20120164846 | Ha et al. | Jun 2012 | A1 |
20120193693 | Kanaya | Aug 2012 | A1 |
20120213940 | Mallick | Aug 2012 | A1 |
20120280200 | Tada et al. | Nov 2012 | A1 |
20120282418 | Chou et al. | Nov 2012 | A1 |
20120315394 | Ito | Dec 2012 | A1 |
20130040447 | Swaminathan et al. | Feb 2013 | A1 |
20130058161 | Yamanaka et al. | Mar 2013 | A1 |
20130058162 | Yamanaka et al. | Mar 2013 | A1 |
20130071580 | Weidman et al. | Mar 2013 | A1 |
20130115783 | Kim et al. | May 2013 | A1 |
20130189854 | Hausmann et al. | Jul 2013 | A1 |
20130196516 | Lavoie et al. | Aug 2013 | A1 |
20130252437 | Sano et al. | Sep 2013 | A1 |
20130309415 | Swaminathan et al. | Nov 2013 | A1 |
20130319329 | Li et al. | Dec 2013 | A1 |
20130344248 | Clark | Dec 2013 | A1 |
20140030444 | Swaminathan et al. | Jan 2014 | A1 |
20140051262 | Lavoie et al. | Feb 2014 | A9 |
20140106574 | Kang et al. | Apr 2014 | A1 |
20140113457 | Sims et al. | Apr 2014 | A1 |
20140120270 | Tour et al. | May 2014 | A1 |
20140120737 | Swaminathan et al. | May 2014 | A1 |
20140134827 | Swaminathan et al. | May 2014 | A1 |
20140141542 | Kang et al. | May 2014 | A1 |
20140141626 | Hausmann et al. | May 2014 | A1 |
20140182619 | Goto et al. | Jul 2014 | A1 |
20140209562 | LaVoie et al. | Jul 2014 | A1 |
20140216337 | Swaminathan et al. | Aug 2014 | A1 |
20140264555 | Ahn et al. | Sep 2014 | A1 |
20140273428 | Shero et al. | Sep 2014 | A1 |
20140295084 | Shirai et al. | Oct 2014 | A1 |
20140302686 | Pan et al. | Oct 2014 | A1 |
20150109814 | Chen et al. | Apr 2015 | A1 |
20150126042 | Pasquale et al. | May 2015 | A1 |
20150147483 | Fukazawa | May 2015 | A1 |
20150159271 | Lee et al. | Jun 2015 | A1 |
20150170900 | LaVoie | Jun 2015 | A1 |
20150206719 | Swaminathan et al. | Jul 2015 | A1 |
20150235835 | Swaminathan et al. | Aug 2015 | A1 |
20150243883 | Swaminathan et al. | Aug 2015 | A1 |
20150249013 | Arghavani et al. | Sep 2015 | A1 |
20160064211 | Swaminathan et al. | Mar 2016 | A1 |
20160118246 | Kang et al. | Apr 2016 | A1 |
20160148800 | Henri et al. | May 2016 | A1 |
20160155676 | Kang et al. | Jun 2016 | A1 |
20160163972 | Swaminathan et al. | Jun 2016 | A1 |
20160293398 | Danek et al. | Oct 2016 | A1 |
20160293838 | Swaminathan et al. | Oct 2016 | A1 |
20160336178 | Swaminathan et al. | Nov 2016 | A1 |
Number | Date | Country |
---|---|---|
1732288 | Feb 2006 | CN |
1926668 | Mar 2007 | CN |
101255548 | Sep 2008 | CN |
101378007 | Mar 2009 | CN |
101416293 | Apr 2009 | CN |
101535524 | Sep 2009 | CN |
101889331 | Nov 2010 | CN |
102906304 | Jan 2013 | CN |
103137864 | Jun 2013 | CN |
0 277 766 | Aug 1988 | EP |
0 541 212 | May 1993 | EP |
1 703 552 | Sep 2006 | EP |
2 278 046 | Jan 2011 | EP |
S48-043472 | Jun 1973 | JP |
H02-093071 | Apr 1990 | JP |
H06-177120 | Jun 1994 | JP |
2001-338922 | Dec 2001 | JP |
2002-134497 | May 2002 | JP |
2002-164345 | Jun 2002 | JP |
2007-180362 | Jul 2007 | JP |
2007-287889 | Nov 2007 | JP |
2007-287890 | Nov 2007 | JP |
2008-500742 | Jan 2008 | JP |
2008-109093 | May 2008 | JP |
4364320 | Aug 2009 | JP |
2009-540128 | Nov 2009 | JP |
2010-10497 | Jan 2010 | JP |
2010-245518 | Oct 2010 | JP |
2011-023576 | Feb 2011 | JP |
2013166965 | Aug 2013 | JP |
2013225655 | Oct 2013 | JP |
10-2001-0111448 | Dec 2001 | KR |
10-0356473 | Oct 2002 | KR |
10-2004-0001036 | Jan 2004 | KR |
10-0734748 | Jul 2007 | KR |
10-2009-0057665 | Jun 2009 | KR |
10-2009-0080019 | Jul 2009 | KR |
10-2009-0081396 | Jul 2009 | KR |
10-20130056608 | May 2013 | KR |
201009942 | Mar 2010 | TW |
201042706 | Dec 2010 | TW |
WO 2004032196 | Apr 2004 | WO |
WO 2006026350 | Mar 2006 | WO |
WO 2006104741 | Oct 2006 | WO |
WO 2007043709 | Apr 2007 | WO |
WO 2007118026 | Oct 2007 | WO |
WO 2011130326 | Oct 2011 | WO |
WO 2011130397 | Oct 2011 | WO |
WO 2012040317 | Mar 2012 | WO |
WO 2012048094 | Apr 2012 | WO |
WO 2012087737 | Jun 2012 | WO |
WO 2013032786 | Mar 2013 | WO |
WO 2013043330 | Mar 2013 | WO |
WO 2013065806 | May 2013 | WO |
WO 2013112727 | Aug 2013 | WO |
Entry |
---|
U.S. Appl. No. 14/194,549, filed Feb. 28, 2014, entitled “Capped Ald Films for Doping Fin-Shaped Channel Regions of 3-D IC Transistors.” |
US Notice of Allowance dated Aug. 7, 2014 issued U.S. Appl. No. 14/133,239. |
US Examiner's Answer to Appeal Brief (filed May 22, 2014) Before the Patent Trial and Appeal Board dated Aug. 14, 2014 issued U.S. Appl. No. 13/224,240. |
US Notice of Allowance dated Oct. 8, 2014 issued in U.S. Appl. No. 13/607,386. |
Korean Final Office Action dated Aug. 18, 2014 issued in KR 10-2012-0043797. |
PCT International Preliminary Report on Patentability and Written Opinion dated Aug. 7, 2014, issued in Application No. PCT/US2013/022977. |
U.S. Appl. No. 14/231,554, filed Mar. 31, 2014, entitled “Plasma Activated Conformal Film Deposition”. |
U.S. Appl. No. 14/133,239, filed Dec. 18, 2013, entitled “Plasma Activated Conformal Dielectric Film Deposition”. |
U.S. Appl. No. 14/074,617, filed Nov. 7, 2013, entitled “Methods for Depositing Films on Sensitive Substrates”. |
U.S. Appl. No. 14/183,287, filed Feb. 18, 2014, entitled “High Growth Rate Process for Conformal Aluminum Nitride.” |
U.S. Appl. No. 14/187,145 , filed Feb. 21, 2014, entitled “Plasma Assisted Atomic Layer Deposition Titanium Oxide for Conformal Encapsulation and Gap Fill Applications.” |
U.S. Appl. No. 14/195,653, filed Mar. 3, 2014, entitled “RF Cycle Purging to Reduce Surface Roughness in Metal Oxide and Metal Nitride Films.” |
U.S. Appl. No. 14/194,324, filed Feb. 28, 2014, entitled “Soft Landing Nanolaminates for Advanced Patterning.” |
US Office Action dated Mar. 15, 2013 issued in U.S. Appl. No. 13/084,399. |
US Final Office Action dated Sep. 13, 2013 issued in U.S. Appl. No. 13/084,399. |
US Notice of Allowance dated Jan. 15, 2014 issued in U.S. Appl. No. 13/084,399. |
US Office Action dated Sep. 14, 2012 issued in U.S. Appl. No. 13/084,305. |
US Final Office Action dated Apr. 25, 2013 issued in U.S. Appl. No. 13/084,305. |
US Office Action dated Apr. 13, 2011 issued in U.S. Appl. No. 12/889,132. |
US Notice of Allowance dated Sep. 30, 2011 issued in U.S. Appl. No. 12/889,132. |
US Office Action dated Aug. 1, 2012 issued in U.S. Appl. No. 13/011,569. |
US Final Office Action dated Feb. 26, 2013 issued in U.S. Appl. No. 13/011,569. |
US Notice of Allowance dated May 6, 2013 issued in U.S. Appl. No. 13/011,569. |
US Office Action dated Apr. 4, 2013 issued U.S. Appl. No. 13/242,084. |
US Notice of Allowance dated Jun. 19, 2013 issued U.S. Appl. No. 13/242,084. |
US Notice of Allowance dated Sep. 19, 2013 issued U.S. Appl. No. 13/242,084. |
US Office Action dated Apr. 29, 2013 issued U.S. Appl. No. 13/224,240. |
US Final Office Action dated Nov. 22, 2013 issued U.S. Appl. No. 13/224,240. |
US Office Action dated Jun. 7, 2013 issued U.S. Appl. No. 13/414,619. |
US Notice of Allowance dated Jul. 26, 2013, issued U.S. Appl. No. 13/414,619. |
US Office Action dated Apr. 11, 2014 issued in U.S. Appl. No. 14/065,334. |
US Office Action dated May 24, 2013 issued U.S. Appl. No. 13/472,282. |
US Notice of Allowance dated Oct. 4, 2013 issued U.S. Appl. No. 13/472,282. |
US Office Action dated May 21, 2014 issued in U.S. Appl. No. 13/607,386. |
US Office Action dated Jun. 13, 2014 issued in U.S. Appl. No. 13/953,616. |
US Office Action dated Jul. 10, 2014 issued in U.S. Appl. No. 14/144,107. |
PCT International Search Report and Written Opinion, dated Oct. 20, 2011, issued in PCT/US2011/032186. |
PCT International Preliminary Report on Patentability, dated Oct. 26, 2012, issued in PCT/US2011/032186. |
PCT Invitation to Pay Additional Fees; Communication Re Partial International Search, dated Dec. 16, 2011, issued in PCT/US2011/032303. |
PCT International Search Report and Written Opinion, dated Feb. 20, 2012, issued in PCT/US2011/032303. |
PCT International Preliminary Report on Patentability and Written Opinion, dated Oct. 26, 2012, issued in PCT/US2011/032303. |
PCT International Search Report and Written Opinion dated May 2, 2012 issued in Application No. PCT/US2011/052537. |
PCT International Preliminary Report on Patentability and Written Opinion dated Apr. 4, 2013 issued in Application No. PCT/US2011/052537. |
PCT International Search Report and Written Opinion dated Dec. 18, 2012, issued in Application No. PCT/US2012/052769. |
PCT International Preliminary Report on Patentability and Written Opinion dated Apr. 3, 2014, issued in Application No. PCT/US2012/052769. |
PCT International Search Report and Written Opinion dated Feb. 28, 2013, issued in Application No. PCT/US2012/051740. |
PCT International Preliminary Report on Patentability and Written Opinion dated Mar. 13, 2014, issued in Application No. PCT/US2012/051740. |
European Extended Search Report dated Apr. 14, 2014 issued in EP 13 15 2046. |
Korean Notice of Provisional Rejection dated Dec. 6, 2013 issued in KR 10-2012-0043797. |
PCT International Search Report and Written Opinion dated May 27, 2013, issued in Application No. PCT/US2013/022977. |
Cecchi et al., (2007) “Ultra-thin conformal pore-sealing of low-k materials by plasma-assisted ALD,” University of New Mexico. Albuquerque, NM. Sandia National Labs, Albuquerque, NM, 1 page. |
Choi, Gyu-Jin et al., (2009) “Plasma-enhanced atomic layer deposition of TiO2 and Al-doped TiO2 films using N2O and O2 reactants,” Journal of the Electrochemical Society, 156(9):G138-G143. |
Hausmann et al. (2002) “Atomic Layer Deposition of Hafnium and Zirconium Oxides Using Metal Amide Precursors,” Chem. Mater. 14(10):4350-4358. |
Kim, H., et al., (2002) “The Growth of Tantalum Thin Films by Plasma-Enhanced Atomic Layer Deposition and Diffusion Barrier Properties,” Mat. Res. Soc. Symp. Proc. 716:B8.5.1-B8.5.6. |
King, Sean W., (Jul./Aug. 2011) “Plasma enhanced atomic layer deposition of SiNx:H and SiO2,” J. Vac. Sci. Technol. A29(4):9 pages. |
Ko, Myoung-Gyun, et al., “Characterization of ruthenium thin film deposited by rf-direct plasma atomic layer deposition,” 209th ECS Meeting, Abstract #50, p. 1 [Downloaded on Jun. 9, 2014]. |
Ko, Myoung-Gyun, et al., (Oct. 2008) “Correlation of Carbon Content with the Thermal Stability of Ruthenium Deposited by Using RF-Direct Plasma-Enhanced Atomic-Layer Deposition,” Journal of the Korean Physical Society, 53(4):2123-2128. |
Lee et al., (2005) “Chemically conformal deposition of SrTiO3 thin films by Atomic Layer Deposition using conventional metal organic precursors and remote-plasma activated H2O,” School of Materials Science and Engineering, and Inter-university Semiconductor Research Center, Seoul National University, Microelectronic Engineering 80:158-161. |
Lee, Jong Ju, (2005) “Low-impurity, highly conformal atomic layer deposition of titanium nitride using NH3-Ar-H2 plasma treatment for capacitor electrodes,” Materials Letters, 59:615-617. |
Li, Xingcun, et al., (2011) “Atomic Layer Deposition Al203 Thin Films in Magnetized Radio Frequency Plasma Source,” Physics Procedia 18:100-106. |
Man P.F. et al., (Feb. 11-15, 1996) “Elimination of Post-Release Adhesion in Microstructures Using Conformal Fluorocarbon Coatings,” MEMS '96 Proceedings, IEEE, pp. 55-60. |
Nguyen, S.V. et al., (Jan./Mar. 1999) “Plasma-assist chemical vapor deposition of dielectric thin films for ULSI semiconductor circuits,” IBM J.Res.Develop. 43(1.2):5-38. |
Plasma Enhanced Atomic Layer Deposition (PEALD), Website: http ://www.asm.com/index.php?option=com—content&task=view&id=19&Itemid=161 (2010), 1 page. |
“P1asmaPro™ NGP®80 Range,” Oxford Instruments (2010), 8 pages. |
Van der Straten et al. (2004) “Atomic layer deposition of tantalum nitride for ultrathin liner applications in advanced copper metallization schemes,” Journal of Materials Research, 19(2):447-453. |
U.S. Appl. No. 14/607,997, filed Jan. 28, 2015, entitled “Plasma Activated Conformal Dielectric Film Deposition”. |
U.S. Appl. No. 14/678,736, filed Apr. 3, 2015, entitled “Deposition of Conformal Films by Atomic Layer Deposition and Atomic Layer Etch.” |
US Final Office Action dated Jun. 10, 2015 issued in U.S. Appl. No. 14/231,554. |
US Office Action dated Mar. 2, 2015 issued in U.S. Appl. No. 14/137,860. |
US Notice of Allowance dated Mar. 19, 2015 issued in U.S. Appl. No. 14/144,107. |
US Office Action dated Jul. 2, 2015 issued in U.S. Appl. No. 14/187,145. |
Chinese First Office Action [no translation] dated Jun. 2, 2015 issued in CN 201180045808.6. |
Korean Trial Decision (English description) dated May 25, 2015 issued in KR 10-2012-0043797. |
U.S. Appl. No. 14/552,011, filed Nov. 24, 2014, entitled “Selective Inhibition in Atomic Layer Deposition of Silicon-Containing Films.” |
US Office Action dated Jan. 2, 2015 issued in U.S. Appl. No. 14/231,554. |
US Notice of Allowance dated Nov. 26, 2014 issued U.S. Appl. No. 14/133,239. |
US Notice of Allowance dated Nov. 19, 2014 issued in U.S. Appl. No. 13/607,386. |
US Final Office Action dated Nov. 24, 2014 issued in U.S. Appl. No. 13/953,616. |
US Office Action dated Dec. 11, 2014 issued in U.S. Appl. No. 14/074,596. |
US Final Office Action dated Jan. 15, 2015 issued in U.S. Appl. No. 14/144,107. |
Puurunen, Riikka L. (2005) “Surface chemistry of atomic layer deposition: A case study for the trimethylaluminum/water process,” Journal of Applied Physics, 97:121301-1-121301-52. |
U.S. Appl. No. 15/201,221, filed Jul. 1, 2016, entitled “Selective Atomic Layer Deposition With Post-Dose Treatment.” |
U.S. Appl. No. 15/253,301, filed Aug. 31, 2016, entitled “Selective Atomic Layer Deposition For Gapfill Using Sacrificial Underlayer.” |
U.S. Appl. No. 15/199,608, filed Jun. 30, 2016, entitled “Apparatus and Method for Deposition and Etch In Gap Fill.” |
US Notice of Allowance dated Aug. 31, 2015 issued in U.S. Appl. No. 14/231,554. |
US Office Action dated Jul. 1, 2016 issued in U.S. Appl. No. 13/963,212. |
US Office Action dated Sep. 21, 2015 issued U.S. Appl. No. 14/607,997. |
US Final Office Action dated Mar. 18, 2016 issued U.S. Appl. No. 14/607,997. |
US Notice of Allowance dated Jun. 16, 2016 issued U.S. Appl. No. 14/607,997. |
US Notice of Allowance dated Sep. 27, 2016 issued U.S. Appl. No. 14/607,997. |
US Patent Board Decision on Appeal Before the Patent Trial and Appeal Board (Examiner Affirmed) dated Aug. 11, 2016 issued U.S. Appl. No. 13/224,240. |
US Notice of Allowance dated Nov. 17, 2016 issued U.S. Appl. No. 13/224,240. |
US Office Action dated Dec. 24, 2015 issued in U.S. Appl. No. 14/074,596. |
US Notice of Allowance dated Feb. 12, 2016 issued in U.S. Appl. No. 14/074,596. |
US Office Action dated May 15, 2015 issued in U.S. Appl. No. 14/074,617. |
US Notice of Allowance dated Nov. 20, 2015 issued in U.S. Appl. No. 14/074,617. |
US Office Action dated Aug. 14, 2015 issued in U.S. Appl. No. 14/061,587. |
US Notice of Allowance dated Feb. 11, 2016 issued in U.S. Appl. No. 14/061,587. |
US Notice of Allowance [Supplemental Notice of Allowability] dated Mar. 1, 2016 issued in U.S. Appl. No. 14/061,587. |
US Notice of Allowance dated Oct. 1, 2015 issued in U.S. Appl. No. 14/137,860. |
US Notice of Allowance [Supplemental Notice of Allowability] dated Oct. 22, 2015 issued in U.S. Appl. No. 14/137,860. |
US Office Action dated Oct. 21, 2015 issued in U.S. Appl. No. 14/194,549. |
US Final Office Action dated Nov. 1, 2016 issued in U.S. Appl. No. 14/194,549. |
US Notice of Allowance dated Aug. 5, 2015 issued in U.S. Appl. No. 14/183,287. |
US Office Action dated Aug. 1, 2016 issued in U.S. Appl. No. 14/932,869. |
US Final Office Action dated Dec. 16, 2015 issued in U.S. Appl. No. 14/187,145. |
US Notice of Allowance dated Feb. 25, 2016 issued in U.S. Appl. No. 14/187,145. |
US Office Action dated Jun. 14, 2016 issued in U.S. Appl. No. 15/019,904. |
US Notice of Allowance dated Oct. 13, 2016 issued in U.S. Appl. No. 15/019,904. |
US Office Action dated Nov. 25, 2016 issued in U.S. Appl. No. 15/178,474. |
US Office Action dated May 25, 2016 issued in U.S. Appl. No. 14/552,011. |
US Notice of Allowance dated Sep. 26, 2016 issued in U.S. Appl. No. 14/552,011. |
US Notice of Allowance dated Jul. 15, 2016 issued in U.S. Appl. No. 14/678,736. |
Taiwan Office Action dated Apr. 27, 2016 issued in Application No. TW 100113041. |
Chinese Second Office Action dated Feb. 2, 2016 issued in Application No. CN 201180045808.6. |
Taiwan Office Action dated May 5, 2016 issued in TW 100134208. |
Chinese First Office Action dated Nov. 19, 2015 issued in Application No. CN 201280046487.6. |
Chinese Second Office Action dated Aug. 22, 2016 issued in Application No. CN 201280046487.6. |
Japanese Office Action dated Aug. 23, 2016 issued in Application No. JP 2014-531838. |
Singapore Supplementary Examination Report dated Jun. 1, 2016 issued in SG 11201400633R. |
Taiwan Notice of Allowance and Search Report dated Dec. 18, 2015 issued in Application No. TW 101134692. |
Chinese First Office Action dated Nov. 6, 2015 issued in Application No. CN 201280053888.4. |
Chinese Second Office Action dated Aug. 16, 2016 issued in Application No. CN 201280053888.4. |
Taiwan Office Action and Search Report dated Jan. 27, 2016 issued in Application No. TW 101131556. |
Taiwan Office Action and Search Report dated Nov. 9, 2016 issued in Application No. TW 101131556. |
Chinese First Office Action dated May 19, 2016 issued in CN 201310021460.8. |
Chinese First Office Action dated Feb. 22, 2016 issued in Application No. CN 201380006994.1. |
Singapore Supplementary Examination Report dated Aug. 11, 2016 issued in SG 11201404315R. |
Taiwan Office Action and Search Report dated Jul. 20, 2016 issued in Application No. TW 102102879. |
Taiwan Office Action dated Oct. 25, 2016 issued in Application No. TW 102117772. |
Chinese First Office Action dated Nov. 28, 2016 issued in Application No. CN 201410521390.7. |
Chinese First Office Action dated Apr. 11, 2016 issued in Application No. CN 201510086588.1. |
Japanese Office Action dated Apr. 19, 2016 issued in Application No. JP 2015-21804. |
Korean First Office Action dated Feb. 19, 2016, issued in Application No. KR 10-2015-0022610. |
Korean Final Office Action dated Jun. 29, 2016, issued in Application No. KR 10-2015-0022610. |
Lavareda et al., (2004) “Properties of a-Si:H TFTs using silicon carbonitride as dielectric,” Journal of Non-Crystalline Solids, 338-340:797-801. |
US Office Action dated Jan. 12, 2017 issued in U.S. Appl. No. 13/963,212. |
US Notice of Allowance (Supplemental Notice of Allowability) dated Feb. 21, 2017 issued U.S. Appl. No. 13/224,240. |
US Office Action dated Feb. 3, 2017 issued in U.S. Appl. No. 14/987,542. |
US Notice of Allowance dated Feb. 10, 2017 issued in U.S. Appl. No. 15/178,474. |
Number | Date | Country | |
---|---|---|---|
20160020092 A1 | Jan 2016 | US | |
20160163539 A9 | Jun 2016 | US |